Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck

Cancer Research

Volumn 64, Issue 1, 2004, Pages 55-63

  Ginos, Matthew A ^a   Page, Grier P ^b   Michalowicz, Bryan S ^c   Patel, Ketan J ^a   Volker, Sonja E ^a   Pambuccian, Stefan E ^a   Ondrey, Frank G ^a   Adams, George L ^a   Gaffney, Patrick M ^a,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Division of Hematology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYCLIN D1; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MYC PROTEIN; PROTEIN P16; PROTEIN P53; RAS PROTEIN;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SQUAMOUS CELL CARCINOMA;

BASE SEQUENCE; BIOPSY; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; FEMALE; GENE EXPRESSION; GENES, MYC; GENES, RAS; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RECURRENCE; REFERENCE VALUES; RNA; RNA, NEOPLASM;

EID: 1642494850     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2144     Document Type: Article

References (79)

1. Edwards, B. K., Howe, H. L., Ries, L. A., Thun, M. J., Rosenberg, H. M., Yancik, R., Wingo, P. A., Jemal, A., and Feigal, E. G. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U. S. cancer burden. Cancer (Phila.), 94: 2766-2792, 2002.
2. Ries, L. A. G., Eisner, M. P., Kosary, C. L., Hankey, B. F., Miller, B. A., Clegg, L., Mariotto, A., Fay, M. P., Feuer, E. J., and Edwards, B. K. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute, 2003.
3. Swango, P. A. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J. Public Health Dent., 56: 309-318, 1996.
4. Smith, B. D., Haffty, B. G., and Sasaki, C. T. Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance. Ann. Otol. Rhinol. Laryngol., 110: 221-228, 2001.
5. Forastiere, A., Koch, W., Trotti, A., and Sidransky, D. Head and neck cancer. N. Engl. J. Med., 345: 1890-1900, 2001.
6. Kiaris, H., Spandidos, D. A., Jones, A. S., Vaughan, E. D., and Field, J. K. Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck. Br. J. Cancer, 72: 123-128, 1995.
7. Hou, M., Davis, S. L., Ames, S. J., and Spanjaard, R. A. Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma. Cancer Res., 62: 7154-7156, 2002.
8. Freier, K., Joos, S., Flechtenmacher, C., Devens, F., Benner, A., Bosch, F. X., Lichter, P., and Hofele, C. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res., 63: 1179-1182, 2003.
9. Rodrigo, J. P., Lazo, P. S., Ramos, S., Alvarez, I., and Suarez, C. MYC amplification in squamous cell carcinomas of the head and neck. Arch. Otolaryngol. Head Neck Surg., 122: 504-507, 1996.
10. Dassonville, O., Formento, J. L., Francoual, M., Ramaioli, A., Santini, J., Schneider, M., Demard, F., and Milano, G. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J. Clin. Oncol., 11: 1873-1878, 1993.
11. Miyaguchi, M., Olofsson, J., and Hellquist, H. B. Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma. Acta Otolaryngol., 110: 309-313, 1990.
12. Berenson, J. R., Yang, J., and Mickel, R. A. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene, 4: 1111-1116, 1989.
13. Callender, T., el-Naggar, A. K., Lee, M. S., Frankenthaler, R., Luna, M. A., and Batsakis, J. G. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Phila.), 74: 152-158, 1994.
14. Jares, P., Fernandez, P. L., Campo, E., Nadal, A., Bosch, F., Aiza, G., Nayach, I., Traserra, J., and Cardesa, A. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54: 4813-4817, 1994.
15. Somers, K. D., Merrick, M. A., Lopez, M. E., Incognito, L. S., Schechter, G. L., and Casey, G. Frequent p53 mutations in head and neck cancer. Cancer Res., 52: 5997-6000, 1992.
16. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
17. Koch, W. M., Brennan, J. A., Zahurak, M., Goodman, S. N., Westra, W. H., Schwab, D., Yoo, G. H., Lee, D. J., Forastiere, A. A., and Sidransky, D. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J. Natl. Cancer Inst. (Bethesda), 88: 1580-1586, 1996.
18. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/1NK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996.
19. Papadimitrakopoulou, V., Izzo, J., Lippman, S. M., Lee, J. S., Fan, Y. H., Clayman, G., Ro, J. Y., Hittelman, W. N., Lotan, R., Hong, W. K., and Mao, L. Frequent inactivation of p161NK4a in oral premalignant lesions. Oncogene, 14: 1799-1803, 1997.
20. Salven, P., Heikkila, P., Anttonen, A., Kajanti, M., and Joensuu, H. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod. Pathol., 10: 1128-1133, 1997.
21. Eisma, R. J., Spiro, J. D., and Kreutzer, D. L. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am. J. Surg., 174: 513-517, 1997.
22. Richards, B. L., Eisma, R. J., Spiro, J. D., Lindquist, R. L., and Kreutzer, D. L. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am. J. Surg., 174: 507-512, 1997.
23. Kaplan, A. S., Caldarelli, D. D., Chacho, M. S., Bruce, D. R., Hutchinson, J., Conway, S., and Coon, J. S. Retrospective DNA analysis of head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 112: 1159-1162, 1986.
24. Sakr, W., Hussan, M., Zarbo, R. J., Ensley, J., and Crissman, J. D. DNA quantitation and histologic characteristics of squamous cell carcinoma of the upper aerodigestive tract. Arch. Pathol. Lab. Med., 113: 1009-1014, 1989.
25. Beder, L. B., Gunduz, M., Ouchida, M., Fukushima, K., Gunduz, E., Ito, S., Sakai, A., Nagai, N., Nishizaki, K., and Shimizu, K. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab. Investig., 83: 99-105, 2003.
26. Califano, J., van der Riet, P., Westra, W., Nawroz, H., Clayman, G., Piantadosi, S., Corio, R., Lee, D., Greenberg, B., Koch, W., and Sidransky, D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res., 56: 2488-2492, 1996.
27. Takebayashi, S., Ogawa, T., Jung, K. Y., Muallem, A., Mineta, H., Fisher, S. G., Grenman, R., and Carey, T. E. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res., 60: 3397-3403, 2000.
28. Ah-See, K. W., Cooke, T. G., Pickford, I. R., Soutar, D., and Balmain, A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res., 54: 1617-1621, 1994.
29. Nutt, C. L., Mani, D. R., Betensky, R. A., Tamayo, P., Caimcross, J. G., Ladd, C., Pohl, U., Hartmann, C., McLaughlin, M. E., Batchelor, T. T., Black, P. M., von Deimling, A., Pomeroy, S. L., Golub, T. R., and Louis, D. N. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res., 63: 1602-1607, 2003.
30. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Jr., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Staudt, L. M., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (Lond.), 403: 503-511, 2000.
31. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde. T., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H., and Bernards, R. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med., 347: 1999-2009, 2002.
32. Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., Scudiero, D. A., Eisen. M. B., Sausville, E. A., Pommier, Y., Botstein, D., Brown, P. O., and Weinstein, J. N. A gene expression database for the molecular pharmacology of cancer. Nat. Genet., 24: 236-244, 2000.
33. Takahashi, M., Rhodes, D. R., Furge, K. A., Kanayama, H., Kagawa, S., Haab, B. B., and Teh, B. T. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl. Acad. Sci. USA, 98: 9754-9759, 2001.
34. West, M., Blanchette, C., Dressman, H., Huang, E., Ishida, S., Spang, R., Zuzan, H., Olson, J. A., Jr., Marks, J. R., and Nevins, J. R. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. USA, 98: 11462-11467, 2001.
35. Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E. J., Lander, E. S., Wong, W., Johnson, B. E., Golub, T. R., Sugarbaker, D. J., and Meyerson, M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA, 98: 13790-13795, 2001.
36. Satterthwaite, F. An approximate distribution of estimates of variance components. Biometrics Bulletin, 2: 110-114, 1946.
37. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-14868, 1998.
38. Allison, D., Gadbury, G., Heo, M., Fernandez, J. R., Lee, C. K., Prolla, T. A., and Weindruch, R. A mixture model approach for the analysis of microarray gene expression data. Comput. Stat. Data Anal., 39: 1-20, 2002.
39. Marshall, D., Hardman, M. J., Nield, K. M., and Byrne, C. Differentially expressed late constituents of the epidermal cornified envelope. Proc. Natl. Acad. Sci. USA, 98: 13031-13036, 2001.
40. Matsumoto, K., Takayama, N., Ohnishi, J., Ohnishi, E., Shirayoshi, Y., Nakatsuji, N., and Ariga, H. Tumour invasion and metastasis are promoted in mice deficient in tenascin X. Genes Cells, 6: 1101-1111, 2001.
41. Chung, C. H., Bernard, P. S., and Perou, C. M. Molecular portraits and the family tree of cancer. Nat. Genet., 32 (Suppl.): 533-540, 2002.
42. Bolos, V., Peinado, H., Perez-Moreno, M. A., Fraga, M. F., Esteller, M., and Cano, A. The transcription factor slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci., 116: 499-511, 2003.
43. Weidner, K. M., Sachs, M., and Birchmeier, W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J. Cell Biol., 121: 145-154, 1993.
44. Khatri, P., Draghici, S., Ostermeier, G. C., and Krawetz, S. A. Profiling gene expression using onto-express. Genomics, 79: 266-270, 2002.
45. Draghici, S., Khatri, P., Martins, R. P., Ostermeier, G. C., and Krawetz, S. A. Global functional profiling of gene expression. Genomics. 81: 98-104, 2003.
46. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., and Sherlock, G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25: 25-29, 2000.
47. Benjamini, Y., and Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B, 57: 289-300, 1995.
48. Rosenberg, S. A. Principles and applications of biologic therapy. In: V. T. De Vita, S. Hellman, and S. A. Rosenberg (eds.), Cancer, Principles and Practice of Oncology, Ed. 4, pp. 293-324. Philadelphia: J. B. Lippincott Co., 1993.
49. Wolf, G. T., Hudson, J. L., Peterson, K. A., Miller, H. L., and McClatchey, K. D. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Otolaryngol. Head Neck Surg., 95: 142-152, 1986.
50. Hiratsuka, H., Imamura, M., Kasai, K., Kamiya, H., Ishii, Y., Kohama, G., and Kikuchi, K. Lymphocyte subpopulations and T-cell subsets in human oral cancer tissues: immunohistologic analysis by monoclonal antibodies. Am. J. Clin. Pathol., 81: 464-470, 1984.
51. Guo, M., Rabin, B. S., Johnson, J. T., and Paradis, I. L. Lymphocyte phenotypes at tumor margins in patients with head and neck cancer. Head Neck Surg., 9: 265-271, 1987.
52. Hirota, J., Ueta, E., Osaki, T., and Ogawa, Y. Immunohistologic study of mononuclear cell infiltrates in oral squamous cell carcinomas. Head Neck, 12: 118-125, 1990.
53. Slootweg, P. J., de Pugter, M., de Weger, R. A., and de Wilde, P. C. Lymphocytes at tumor margins in patients with head and neck cancer. Relationship with tumor size, human lymphocyte antigen molecules, and metastasis. Int. J. Oral Maxillofac. Surg., 23: 286-289, 1994.
54. Kuss, I., Saito, T., Johnson, J. T., and Whiteside, T. L. Clinical significance of decreased ζ chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin. Cancer Res., 5: 329-334, 1999.
55. Gastman, B. R., Atarshi, Y., Reichert, T. E., Saito, T., Balkir, L., Rabinowich, H., and Whiteside, T. L. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res., 59: 5356-5364, 1999.
56. Reichert, T. E., Strauss, L., Wagner, E. M., Gooding, W., and Whiteside, T. L. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin. Cancer Res., 8: 3137-3145, 2002.
57. Chen, Z., Malhotra, P. S., Thomas, G. R., Ondrey, F. G., Duffey, D. C., Smith, C. W., Enamorado, I., Yeh, N. T., Kroog, G. S., Rudy, S., McCullagh, L., Mousa, S., Quezado, M., Herscher, L. L., and Van Waes, C. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin. Cancer Res., 5: 1369-1379, 1999.
58. Trusolino, L., and Comoglio, P. M. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev. Cancer, 2: 289-300, 2002.
59. Cortesina, G., Martone, T., Galeazzi, E., Olivero, M., De Stefani, A., Bussi, M., Valente, G., Comoglio, P. M., and Di Renzo, M. F. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int. J. Cancer, 89: 286-292, 2000.
60. Galeazzi, E., Olivero, M., Gervasio, F. C., De Stefani, A., Valente, G., Comoglio, P. M., Di Renzo, M. F., and Cortesina, G. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. Eur. Arch. Otorhinolaryngol., 254 (Suppl. 1): S138-S143, 1997.
61. Qian, C. N., Guo, X., Cao, B., Kort, E. J., Lee, C. C., Chen, J., Wang, L. M., Mai, W. Y., Min, H. Q., Hong, M. H., Vande Woude, G. F., Resau, J. H., and Teh, B. T. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res., 62: 589-596, 2002.
62. Zeng, Q., Chen, S., You, Z., Yang, F., Carey, T. E., Saims, D., and Wang, C. Y. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NF-κB. J. Biol. Chem., 277: 25203-25208, 2002.
63. Savagner, P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays, 23: 912-923, 2001.
64. Hajra, K. M., Chen, D. Y., and Fearon, E. R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res., 62: 1613-1618, 2002.
65. Inoue, A., Seidel, M. G., Wu, W., Kamizono, S., Ferrando, A. A., Bronson, R. T., Iwasaki, H., Akashi, K., Morimoto, A., Hitzler, J. K., Pestina, T. I., Jackson, C. W., Tanaka, R., Chong, M. J., McKinnon, P. J., Inukai, T., Grosveld, G. C., and Look, A. T. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell, 2: 279-288, 2002.
66. Patarroyo, M., Tryggvason, K., and Virtanen, I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin. Cancer Biol., 12: 197-207, 2002.
67. Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., and Khavari, P. A. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature (Lond.), 421: 639-643, 2003.
68. Belbin, T. J., Singh, B., Barber, I., Socci, N., Wenig, B., Smith, R., Prystowsky, M. B., and Childs, G. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res., 62: 1184-1190, 2602.
69. Mendez, E., Cheng, C., Farwell, D. G., Ricks, S., Agoff, S. N., Futran, N. D., Weymuller, E. A., Jr., Maronian, N. C., Zhao, L. P., and Chen, C. Transcriptional expression profiles of oral squamous cell carcinomas. Cancer (Phila.), 95: 1482-1494, 2002.
70. Hasina, R., Hulett, K., Bicciato, S., Di Bello, C., Petruzzelli, G. J., and Lingen, M. W. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. Cancer Res., 63: 555-559, 2003.
71. Higuchi, E., Oridate, N., Furuta, Y., Suzuki, S., Hatakeyama, H., Sawa, H., Sunayashiki-Kusuzaki, K., Yamazaki, K., Inuyama, Y., and Fukuda, S. Differentially expressed genes associated with cis-diamminedichloroplatinum (11) resistance in head and neck cancer using differential display and CDNA microarray. Head Neck, 25: 187-193, 2003.
72. Narita, N., Noda, I., Ohtsubo, T., Fujieda, S., Tokuriki, M., Saito, T., and Saito, H. Analysis of heat-shock related gene expression in head-and-neck cancer using cDNA arrays. Int. J. Radiat. Oncol. Biol. Phys., 53: 190-196, 2002.
73. Dimitroulakos, J., Marhin, W. H., Tokunaga, J., Irish, J., Gullane, P., Penn, L. Z., and Kamel-Reid, S. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas. Neoplasia, 4: 337-346, 2002.
74. Leethanakul, C., Patel, V., Gillespie, J., Shillitoe, E., Kellman, R. M., Ensley. J. F., Limwongse, V., Emmert-Buck, M. R., Krizman, D. B., and Gutkind, J. S. Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Oncol., 36: 474-483, 2000.
75. Hartmann, K. A., Modlich, O., Prisack, H. B., Gerlach, B., and Bojar, H. Gene expression profiling of advanced head and neck squamous cell carcinomas and two squamous cell carcinoma cell lines under radio/chemotherapy using cDNA arrays. Radiother. Oncol., 63: 309-320, 2002.
76. El-Naggar, A. K., Kim, H. W., Clayman, G. L., Coombes, M. M., Le, B., Lai, S., Zhan, F., Luna, M. A., Hong, W. K., and Lee, J. J. Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification. Oncogene, 21: 8206-8219, 2002.
77. Squire, J. A., Bayani, J., Luk, C., Unwin, L., Tokunaga, J., MacMillan, C., Irish, J., Brown, D., Gullane, P., and Kamel-Reid, S. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck, 24: 874-887, 2002.
78. Yoo, G. H., Piechocki, M. P., Ensley, J. F., Nguyen, T., Oliver, J., Meng, H., Kewson, D., Shibuya, T. Y., Lonardo, F., and Tainsky, M. A. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot. Clin. Cancer Res., 8: 3910-3921, 2002.
79. Al Moustafa, A. E., Alaoui-Jamali, M. A., Batist, G., Hernandez-Perez, M., Serruya, C., Alpert, L., Black, M. J., Sladek, R., and Foulkes, W. D. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene, 21: 2634-2640, 2002.